An electromagnetic wave detector including a first electromagnetic wave sensor including a light reception unit held in midair above a substrate by a support leg and a second electromagnetic wave sensor including a light reception unit held in midair above the substrate by a support leg having same structure as the support leg of the first electromagnetic wave sensor and provided adjacent to the first electromagnetic wave sensor. The light reception unit of the first electromagnetic wave sensor includes a reflective film, the light reception unit of the second electromagnetic wave sensor includes an electromagnetic wave absorption body for detecting light of a prescribed wavelength band or a prescribed polarization, and the difference between the output of the second electromagnetic wave sensor and the first electromagnetic wave sensor is output.

A method of avoiding a contaminant which would skew an analyte result in a breath analysis method and of calibrating subject of the breath analysis includes, immediately before the breath analysis method or the collection of breath for the breath analysis method, administering to the subject a predetermined gas composition. A system for analyzing an analyte in breath of a subject while avoiding a local contaminant which would skew an analyte result and calibrating the subject of so that the result of the analyte analysis will be the same regardless of where the test is performed geographically, includes a source of a predetermined gas composition immediately before the breath analysis method or the collection of gas for the breath analysis method, administering to the subject a predetermined gas mixture.

A method through which a more rapid detection of Helicobacter pylori in a gaseous sample is practicable, in which the .sup.13C content is measured only until a minimum number of measurement values of the .sup.13C content meets a standard deviation to be specified. The known .sup.13C urea breath test has become established for clinical diagnosis for detecting Helicobacter pylori infections and known methods for detecting Helicobacter pylori provide that each method step corresponds to a fixed, specified time, which is disadvantageous, especially for performing a large number of such tests.

A method through which a more rapid detection of Helicobacter pylori in a gaseous sample is practicable, in which the .sup.13C content is measured only until a minimum number of measurement values of the .sup.13C content meets a standard deviation to be specified. The known .sup.13C urea breath test has become established for clinical diagnosis for detecting Helicobacter pylori infections and known methods for detecting Helicobacter pylori provide that each method step corresponds to a fixed, specified time, which is disadvantageous, especially for performing a large number of such tests.

Methods for identifying premature infants at risk for developing bronchopulmonary dysplasia and/or most likely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia (BPD). Methods for treating premature infants identified as at risk and/or likely to benefit are provided. also provided are methods for identifying premature infants that are not at risk for developing bronchopulmonary dysplasia and/or unlikely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia, and methods for avoiding risks of toxicity and undesirable side effects associated with inhaled nitric oxide therapy comprising administering only non-iNO treatment modalities to these infants.

Methods for identifying premature infants at risk for developing bronchopulmonary dysplasia and/or most likely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia (BPD). Methods for treating premature infants identified as at risk and/or likely to benefit are provided. also provided are methods for identifying premature infants that are not at risk for developing bronchopulmonary dysplasia and/or unlikely to benefit from administration of inhaled nitric oxide for prevention of bronchopulmonary dysplasia, and methods for avoiding risks of toxicity and undesirable side effects associated with inhaled nitric oxide therapy comprising administering only non-iNO treatment modalities to these infants.

A system for testing alcohol breath analyzers, wherein the system comprises an alcohol breath gas generation device, a test chamber, a reference measuring device, a control and registration unit, and a distribution unit. The invention also relates to methods of testing alcohol breath analyzers.

A system is provided that detects the odor of air exhaled from a subject. Based on affection information and the odor, the system indicates features of the exhaled air related to a disease based on measurement information in which the affection information indicates affection or non-affection. The system also detects the odor in the air from a medical examinee. Based on the measurement information and the features, the system determines the possibility that the medical examinee will be affected with a disease.

A system is provided that detects the odor of air exhaled from a subject. Based on affection information and the odor, the system indicates features of the exhaled air related to a disease based on measurement information in which the affection information indicates affection or non-affection. The system also detects the odor in the air from a medical examinee. Based on the measurement information and the features, the system determines the possibility that the medical examinee will be affected with a disease.

The virus test device encompasses a pseudo-receptor film having pseudo-receptors mimicking a structure of a host-cell receptor, which binds specifically to a target virus, a virus introducing-tube for sucking down an air-under-test (AUT) containing the target viruses, to compress the AUT into a high-speed air-flow of aerosols-under-test, concentrating the target viruses contained in the AUT, and to eject the high-speed air-flow to the pseudo-receptor film, a signal conditioner for converting physical signals, which represent alterations of physical states of the pseudo-receptor film ascribable to specific bindings of the pseudo-receptors with the target viruses, to electric signals.